NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies

  1. Sandrine Moutel
  2. Nicolas Bery
  3. Virginie Bernard
  4. Laura Keller
  5. Emilie Lemesre
  6. Ario de Marco
  7. Laetitia Ligat
  8. Jean-Christophe Rain
  9. Gilles Favre
  10. Aurélien Olichon  Is a corresponding author
  11. Franck Perez  Is a corresponding author
  1. Institut Curie, France
  2. Inserm, UMR 1037-CRCT, France
  3. CRCT, France
  4. Hybrigenics Service SA, France

Abstract

In vitro selection of antibodies allows to obtain highly functional binders, rapidly and at lower cost. Here, we describe the first fully synthetic phage display library of humanized llama single domain antibody (NaLi-H1: Nanobody Library Humanized 1). Based on a humanized synthetic single domain antibody (hs2dAb) scaffold optimized for intracellular stability, the highly diverse library provides high affinity binders without animal immunization. NaLi-H1 was screened following several selection schemes against various targets (Fluorescent proteins, actin, tubulin, p53, HP1). Conformation antibodies against active RHO GTPase were also obtained. Selected hs2dAb were used in various immunoassays and were often found to be functional intrabodies, enabling tracking or inhibition of endogenous targets. Functionalization of intrabodies allowed specific protein knockdown in living cells. Finally, direct selection against the surface of tumor cells produced hs2dAb directed against tumor-specific antigens further highlighting the potential use of this library for therapeutic applications.

Article and author information

Author details

  1. Sandrine Moutel

    Institut Curie, Paris, France
    Competing interests
    Sandrine Moutel, Co-inventor on a patent application (filled under ref: WO/2015/063331) that covers the hs2dAb scaffold and the commercial use of the library. The library has been licensed to Hybrigenics Service SA, which will perform screens on a fee-for-service basis.A consultant for Hybrigenics Service SA.
  2. Nicolas Bery

    Inserm, UMR 1037-CRCT, Toulouse, France
    Competing interests
    No competing interests declared.
  3. Virginie Bernard

    Institut Curie, Paris, France
    Competing interests
    No competing interests declared.
  4. Laura Keller

    Inserm, UMR 1037-CRCT, Toulouse, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1786-9760
  5. Emilie Lemesre

    Institut Curie, Paris, France
    Competing interests
    No competing interests declared.
  6. Ario de Marco

    Institut Curie, Paris, France
    Competing interests
    No competing interests declared.
  7. Laetitia Ligat

    plateau de protéomique, CRCT, Toulouse, France
    Competing interests
    No competing interests declared.
  8. Jean-Christophe Rain

    Hybrigenics Service SA, Paris, France
    Competing interests
    Jean-Christophe Rain, Employed by, and a stockholder in, Hybrigenics Service SA.
  9. Gilles Favre

    Inserm, UMR 1037-CRCT, Toulouse, France
    Competing interests
    No competing interests declared.
  10. Aurélien Olichon

    Inserm, UMR 1037-CRCT, Toulouse, France
    For correspondence
    aurelien.olichon@inserm.fr
    Competing interests
    Aurélien Olichon, Co-inventor on a patent application (filled under ref: WO/2015/063331) that covers the hs2dAb scaffold and the commercial use of the library. The library has been licensed to Hybrigenics Service SA, which will perform screens on a fee-for-service basis.
  11. Franck Perez

    Institut Curie, Paris, France
    For correspondence
    Franck.Perez@curie.fr
    Competing interests
    Franck Perez, Co-inventor on a patent application (filled under ref: WO/2015/063331) that covers the hs2dAb scaffold and the commercial use of the library. The library has been licensed to Hybrigenics Service SA, which will perform screens on a fee-for-service basis.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9129-9401

Funding

Institut Curie

  • Sandrine Moutel
  • Virginie Bernard
  • Ario de Marco
  • Franck Perez

Centre National de la Recherche Scientifique

  • Sandrine Moutel
  • Franck Perez

Institut National de la Santé et de la Recherche Médicale

  • Nicolas Bery
  • Laura Keller
  • Laetitia Ligat
  • Gilles Favre
  • Aurélien Olichon

Agence Nationale de la Recherche (ANR-09-BIOT-05)

  • Sandrine Moutel
  • Jean-Christophe Rain
  • Franck Perez

Institut National de la Santé et de la Recherche Médicale (ITS-201103)

  • Ario de Marco
  • Franck Perez

Fondation pour la Recherche Médicale (DEQ20120323723)

  • Franck Perez

Groupe de Recherche of the Claudius Regaud Institute

  • Gilles Favre
  • Aurélien Olichon

LABEX CellTisPhyBio (11-LBX-0038)

  • Sandrine Moutel
  • Virginie Bernard
  • Ario de Marco
  • Franck Perez

IDEX Paris Sciences Lettres (ANR-10-IDEX-0001-02 PSL)

  • Sandrine Moutel
  • Virginie Bernard
  • Ario de Marco
  • Franck Perez

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2016, Moutel et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sandrine Moutel
  2. Nicolas Bery
  3. Virginie Bernard
  4. Laura Keller
  5. Emilie Lemesre
  6. Ario de Marco
  7. Laetitia Ligat
  8. Jean-Christophe Rain
  9. Gilles Favre
  10. Aurélien Olichon
  11. Franck Perez
(2016)
NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies
eLife 5:e16228.
https://doi.org/10.7554/eLife.16228

Share this article

https://doi.org/10.7554/eLife.16228

Further reading

    1. Cell Biology
    Kaili Du, Hongyu Chen ... Dan Li
    Research Article

    Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.

    1. Cell Biology
    2. Developmental Biology
    Sarah Y Coomson, Salil A Lachke
    Insight

    A study in mice reveals key interactions between proteins involved in fibroblast growth factor signaling and how they contribute to distinct stages of eye lens development.